Owkin
Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medica…
OncoGenomX
OncoGenomX is a prediction software company known for its revolutionary approach to individualized drug-tumor matching, with the mission to end under- and overtreatment of patients, avoid unnecessary costs, and minimize the risk of failure and liability.
IPDx
The humoral immune system monitors and regulates human health via antibodies. IPDx proprietary technology translates the intricate collection of antibodies into actionable data to develop diagnostics that help detect disease earlier and guide treatment decisions.
eMurmur
eMurmur is a technology partner to the global healthcare community specializing in advanced digital auscultation. Supporting heart, lung, and bowel health screenings, the company seeks to elevate the practice of auscultation in every interaction.
Deepeye
deepeye is a decision support algorithm that enables ophthalmologists to provide individual therapy to patients suffering from popular eye diseases like Age-related Macular Degeneration (AMD) and o…
Clue
Clue is a period and cycle tracking app that calculates and predicts users’ periods and PMS based on users’ data and calculates fertility windows based on global averages, which can be made more accurate by users’ entering ovulation test data. Clue has more than 10 million active users.
Selfdiagnostics
Selfdiagnostics is an Estonian-German certified research and development company of Estonian origin established in 2008, which is engaged in the development, production and sale of medical devices. The company’s product portfolio includes a variety of medical devices for professional and home use – diagnostic tests, inhalers and blood pressure monitors.
OmicEra Diagnostics
OmicEra offers cutting-edge MS-based proteome analysis to understand human health and disease states. OmicEra is now part of Exact Sciences.
Lys Therapeutics
Lys Therapeutics is a biotechnology company pioneering a breakthrough approach to treat patients suffering from neurodegenerative or neurovascular disorders. Its main drug is a first-in-class monoclonal antibody, Glunozumab, displaying an exclusive and groundbreaking mechanism of action.
Sensible Biotechnologies
Sensible Biotechnologies is developing a cost-efficient and scalable platform for the production of high-quality mRNA to enable the next generation of mRNA therapeutics and vaccines.
